Literature DB >> 18370497

The Development and Psychometric Properties of the MSQOL: A Migraine-Specific Quality-of-Life Instrument.

S P McKenna1, L C Doward, K M Davey.   

Abstract

This paper describes the development and testing of the UK version of the Migraine-Specific Quality-of-Life instrument (MSQOL), a measure designed to assess the quality of life of migraineurs. The work was part of an international research study conducted in eight countries, with the initial development work conducted in the UK and the USA. In the UK, interviews were held with 30 patients with migraine, while in the USA, 25 individual interviews were conducted, along with one focus group with 5 participants. Transcripts were produced of the interviews/group discussion and these were used to determine the questionnaire items, which were then considered by an international translation panel. The panel considered the feasibility of translating the items into other European languages. The instrument was then assessed for reliability and validity. The UK version of the MSQOL was shown to have excellent test-retest reliability (0.93 over 2 weeks) and internal consistency (0.92 and 0.93 on the first and second administrations, respectively). Scores on the measure were also found to be related to a comparator measure of well-being and to perceived severity of migraine and disruption caused to patients by the disease. Findings for the other language versions of the MSQOL supported those from the UK, suggesting that the instrument may well be suitable for inclusion in clinical trials.

Entities:  

Year:  1998        PMID: 18370497     DOI: 10.2165/00044011-199815050-00006

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  30 in total

1.  The concept of illness behavior.

Authors:  D MECHANIC
Journal:  J Chronic Dis       Date:  1962-02

2.  Personality and migraine.

Authors:  S M Baskin
Journal:  Headache       Date:  1995 Jul-Aug       Impact factor: 5.887

3.  The QLDS: a scale for the measurement of quality of life in depression.

Authors:  S M Hunt; S P McKenna
Journal:  Health Policy       Date:  1992-10       Impact factor: 2.980

4.  Conceptualizing and defining outcome.

Authors:  A Tennant; S P McKenna
Journal:  Br J Rheumatol       Date:  1995-10

5.  Quality of life assessment among migraine patients treated with sumatriptan.

Authors:  G D Solomon; F G Skobieranda; J R Genzen
Journal:  Headache       Date:  1995-09       Impact factor: 5.887

6.  Cross-cultural development of a quality of life measure for men with erection difficulties.

Authors:  T H Wagner; D L Patrick; S P McKenna; P S Froese
Journal:  Qual Life Res       Date:  1996-08       Impact factor: 4.147

Review 7.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

8.  An epidemiologic study of headache among adolescents and young adults.

Authors:  M S Linet; W F Stewart; D D Celentano; D Ziegler; M Sprecher
Journal:  JAMA       Date:  1989-04-21       Impact factor: 56.272

9.  Improvements in health-related quality of life with sumatriptan treatment for migraine.

Authors:  P Jhingran; R K Cady; J Rubino; D Miller; R B Grice; D L Gutterman
Journal:  J Fam Pract       Date:  1996-01       Impact factor: 0.493

10.  A quality of life instrument for adolescents with chronic headache.

Authors:  J H Langeveld; H M Koot; M C Loonen; A A Hazebroek-Kampschreur; J Passchier
Journal:  Cephalalgia       Date:  1996-05       Impact factor: 6.292

View more
  8 in total

1.  The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.

Authors:  S P McKenna; N Doughty; D M Meads; L C Doward; J Pepke-Zaba
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

2.  The development of a quality of life instrument for use with post-menopausal women with urogenital atrophy in the UK and Sweden.

Authors:  S P McKenna; D Whalley; U Renck-Hooper; S Carlin; L C Doward
Journal:  Qual Life Res       Date:  1999-08       Impact factor: 4.147

3.  Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire.

Authors:  Lynda C Doward; Stephen P McKenna; David M Meads; James Twiss; Dennis Revicki; Robert L Wong; Michelle P Luo
Journal:  Health Qual Life Outcomes       Date:  2007-02-02       Impact factor: 3.186

4.  Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs).

Authors:  Kirstie L Haywood; Tom S Mars; Rachel Potter; Shilpa Patel; Manjit Matharu; Martin Underwood
Journal:  Cephalalgia       Date:  2017-09-18       Impact factor: 6.292

5.  Chronic Headache Education and Self-management Study (CHESS) - a mixed method feasibility study to inform the design of a randomised controlled trial.

Authors:  Kimberley White; Rachel Potter; Shilpa Patel; Vivien P Nichols; Kirstie L Haywood; Siew Wan Hee; Dipesh Mistry; Dawn Carnes; Stephanie J C Taylor; Martin Underwood; Manjit S Matharu
Journal:  BMC Med Res Methodol       Date:  2019-02-11       Impact factor: 4.615

Review 6.  Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative Review.

Authors:  Carrie R Houts; R J Wirth; James S McGinley; Chad Gwaltney; Eric Kassel; Steven Snapinn; Roger Cady
Journal:  Headache       Date:  2019-12-06       Impact factor: 5.887

7.  Quality of life in rural and urban populations in Lebanon using SF-36 health survey.

Authors:  Ibtissam Sabbah; Nabil Drouby; Sanaa Sabbah; Nathalie Retel-Rude; Mariette Mercier
Journal:  Health Qual Life Outcomes       Date:  2003-08-06       Impact factor: 3.186

8.  Usual care and a self-management support programme versus usual care and a relaxation programme for people living with chronic headache disorders: a randomised controlled trial protocol (CHESS).

Authors:  Shilpa Patel; Felix Achana; Dawn Carnes; Sandra Eldridge; David R Ellard; Frances Griffiths; Kirstie Haywood; Siew Wan Hee; Dipesh Mistry; Hema Mistry; Vivien P Nichols; Stavros Petrou; Tamar Pincus; Rachel Potter; Harbinder Kaur Sandhu; Kimberley Stewart; Stephanie Taylor; Martin Underwood; Manjit Matharu
Journal:  BMJ Open       Date:  2020-04-12       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.